-
1
-
-
43549091657
-
Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry
-
Kaneku HK, Terasaki PI. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry. Clin Transpl 2006: 1-27.
-
(2006)
Clin Transpl
, pp. 1-27
-
-
Kaneku, H.K.1
Terasaki, P.I.2
-
2
-
-
0031778798
-
Protecting single-kidney allografts from long-term functional deterioration
-
Remuzzi G, Perico N. Protecting single-kidney allografts from long-term functional deterioration. J Am Soc Nephrol 1998; 9: 1321-1332.
-
(1998)
J Am Soc Nephrol
, vol.9
, pp. 1321-1332
-
-
Remuzzi, G.1
Perico, N.2
-
3
-
-
0001363498
-
Nephron adaptation to renal injury or ablation
-
Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985; 249: F324-F337.
-
(1985)
Am J Physiol
, vol.249
-
-
Brenner, B.M.1
-
4
-
-
0031046924
-
Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft
-
Azuma H, Nadeau K, Mackenzie HS et al. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997; 63: 519-528.
-
(1997)
Transplantation
, vol.63
, pp. 519-528
-
-
Azuma, H.1
Nadeau, K.2
MacKenzie, H.S.3
-
6
-
-
34548859562
-
Sirolimus: Defining nephrotoxicity in the renal transplant recipient
-
Tomlanovich SJ, Vincenti F. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol 2007; 2: 198-199.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 198-199
-
-
Tomlanovich, S.J.1
Vincenti, F.2
-
7
-
-
32444451549
-
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
-
Remuzzi G, Benigni A, Remuzzi A. Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. J Clin Invest 2006; 116: 288-296.
-
(2006)
J Clin Invest
, vol.116
, pp. 288-296
-
-
Remuzzi, G.1
Benigni, A.2
Remuzzi, A.3
-
9
-
-
0033780696
-
Recommendations for the outpatient surveillance of renal transplant recipients
-
American Society of Transplantation
-
Kasiske BL, Vazquez MA, Harmon WE et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 15: S1-S86.
-
(2000)
J Am Soc Nephrol
, vol.15
-
-
Kasiske, B.L.1
Vazquez, M.A.2
Harmon, W.E.3
-
11
-
-
0026878341
-
Cyclosporine and posttransplant hypertension
-
Curtis JJ. Cyclosporine and posttransplant hypertension. J Am Soc Nephrol 1992; 2: S243-S245.
-
(1992)
J Am Soc Nephrol
, vol.2
-
-
Curtis, J.J.1
-
12
-
-
0034594631
-
Arterial hypertension and renal allograft survival
-
Mange KC, Cizman B, Joffe M et al. Arterial hypertension and renal allograft survival. JAMA 2000; 283: 633-638.
-
(2000)
JAMA
, vol.283
, pp. 633-638
-
-
Mange, K.C.1
Cizman, B.2
Joffe, M.3
-
13
-
-
0033852481
-
Preserving renal function in adults with hypertension and diabetes: A consensus approach
-
National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group
-
Bakris GL, Williams M, Dworkin L et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. Am J Kidney Dis 2000; 36: 646-661.
-
(2000)
Am J Kidney Dis
, vol.36
, pp. 646-661
-
-
Bakris, G.L.1
Williams, M.2
Dworkin, L.3
-
14
-
-
19944432352
-
Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age
-
Svetkey LP, Erlinger TP, Vollmer WM et al. Effect of lifestyle modifications on blood pressure by race, sex, hypertension status, and age. J Hum Hypertens 2005; 19: 21-31.
-
(2005)
J Hum Hypertens
, vol.19
, pp. 21-31
-
-
Svetkey, L.P.1
Erlinger, T.P.2
Vollmer, W.M.3
-
15
-
-
9044253049
-
Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients
-
Harper SJ, Moorhouse J, Veitch PS et al. Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. Transpl Int 1992; 5(Suppl 1): S69-S72.
-
(1992)
Transpl Int
, vol.5
, Issue.SUPPL. 1
-
-
Harper, S.J.1
Moorhouse, J.2
Veitch, P.S.3
-
16
-
-
37349034394
-
Reduced exposure to calcineurin inhibitors in renal transplantation
-
Ekberg H, Tedesco-Silva H, Demirbas A et al. Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 2007; 357: 2562-2575.
-
(2007)
N Engl J Med
, vol.357
, pp. 2562-2575
-
-
Ekberg, H.1
Tedesco-Silva, H.2
Demirbas, A.3
-
17
-
-
0037145856
-
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial
-
Wright Jr JT, Bakris G, Greene T et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 2002; 288: 2421-2431.
-
(2002)
JAMA
, vol.288
, pp. 2421-2431
-
-
Wright Jr., J.T.1
Bakris, G.2
Greene, T.3
-
18
-
-
0035816018
-
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A randomized controlled trial
-
Agodoa LY, Appel L, Bakris GL et al. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 2001; 285: 2719-2728.
-
(2001)
JAMA
, vol.285
, pp. 2719-2728
-
-
Agodoa, L.Y.1
Appel, L.2
Bakris, G.L.3
-
19
-
-
48549095799
-
Angiotensin receptor blockers: Current status and future prospects
-
Ram CV. Angiotensin receptor blockers: current status and future prospects. Am J Med 2008; 121: 656-663.
-
(2008)
Am J Med
, vol.121
, pp. 656-663
-
-
Ram, C.V.1
-
20
-
-
19644400972
-
Angiotensin-converting-enzyme inhibition in stable coronary artery disease
-
Braunwald E, Domanski MJ, Fowler SE et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058-2068.
-
(2004)
N Engl J Med
, vol.351
, pp. 2058-2068
-
-
Braunwald, E.1
Domanski, M.J.2
Fowler, S.E.3
-
21
-
-
0030604561
-
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
-
The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)
-
Ruggenenti P, Perna A, Mosconi L et al. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet 1997; 349: 1857-1863.
-
(1997)
Lancet
, vol.349
, pp. 1857-1863
-
-
Ruggenenti, P.1
Perna, A.2
Mosconi, L.3
-
22
-
-
36849003353
-
Is RAS blockade routinely indicated in hypertensive kidney transplant patients?
-
Salzberg DJ. Is RAS blockade routinely indicated in hypertensive kidney transplant patients? Curr Hypertens Rep 2007; 9: 422-429.
-
(2007)
Curr Hypertens Rep
, vol.9
, pp. 422-429
-
-
Salzberg, D.J.1
-
23
-
-
33748778507
-
Cardiovascular complications after renal transplantation and their prevention
-
Ojo AO. Cardiovascular complications after renal transplantation and their prevention. Transplantation 2006; 82: 603-611.
-
(2006)
Transplantation
, vol.82
, pp. 603-611
-
-
Ojo, A.O.1
-
24
-
-
0024210425
-
Proteinuria in renal transplant recipients: Incidence, cause, prognostic importance
-
Bear RA, Aprile M, Sweet J et al. Proteinuria in renal transplant recipients: incidence, cause, prognostic importance. Transplant Proc 1988; 20: 1235-1236.
-
(1988)
Transplant Proc
, vol.20
, pp. 1235-1236
-
-
Bear, R.A.1
Aprile, M.2
Sweet, J.3
-
26
-
-
30344442801
-
Angiotensin II: A key factor in the inflammatory and fibrotic response in kidney diseases
-
Ruiz-Ortega M, Ruperez M, Esteban V et al. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 2006; 21: 16-20.
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 16-20
-
-
Ruiz-Ortega, M.1
Ruperez, M.2
Esteban, V.3
-
27
-
-
1242351306
-
The renin-angiotensin-aldosterone system and the kidney: Effects on kidney disease
-
Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116: 263-272.
-
(2004)
Am J Med
, vol.116
, pp. 263-272
-
-
Brewster, U.C.1
Perazella, M.A.2
-
28
-
-
0344514607
-
ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established
-
Noris M, Mister M, Pezzotta A et al. ACE inhibition limits chronic injury of kidney transplant even with treatment started when lesions are established. Kidney Int 2003; 64: 2253-2261.
-
(2003)
Kidney Int
, vol.64
, pp. 2253-2261
-
-
Noris, M.1
Mister, M.2
Pezzotta, A.3
-
29
-
-
33645451066
-
Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation
-
Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889-899.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 889-899
-
-
Heinze, G.1
Mitterbauer, C.2
Regele, H.3
-
30
-
-
34548301629
-
Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence
-
Hiremath S, Fergusson D, Doucette S et al. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7: 2350-2360.
-
(2007)
Am J Transplant
, vol.7
, pp. 2350-2360
-
-
Hiremath, S.1
Fergusson, D.2
Doucette, S.3
-
31
-
-
13444267698
-
Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection
-
Dragun D, Muller DN, Brasen JH et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-569.
-
(2005)
N Engl J Med
, vol.352
, pp. 558-569
-
-
Dragun, D.1
Muller, D.N.2
Brasen, J.H.3
-
32
-
-
44449094269
-
The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation- study design
-
Knoll GA, Cantarovitch M, Cole E et al. The Canadian ACE-inhibitor trial to improve renal outcomes and patient survival in kidney transplantation- study design. Nephrol Dial Transplant 2008; 23: 354-358.
-
(2008)
Nephrol Dial Transplant
, vol.23
, pp. 354-358
-
-
Knoll, G.A.1
Cantarovitch, M.2
Cole, E.3
-
33
-
-
53549111038
-
Dyslipidemia in chronic kidney disease: An approach to pathogenesis and treatment
-
Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment. Am J Nephrol 2008; 28: 958-973.
-
(2008)
Am J Nephrol
, vol.28
, pp. 958-973
-
-
Tsimihodimos, V.1
Dounousi, E.2
Siamopoulos, K.C.3
-
34
-
-
3242666237
-
The effects of hyperlipidaemia on graft and patient outcome in renal transplantation
-
Del Castillo D, Cruzado JM, Manel Diaz J et al. The effects of hyperlipidaemia on graft and patient outcome in renal transplantation. Nephrol Dial Transplant 2004; 19(Suppl 3): iii67-iii71.
-
(2004)
Nephrol Dial Transplant
, vol.19
, Issue.SUPPL. 3
-
-
Del Castillo, D.1
Cruzado, J.M.2
Manel Diaz, J.3
-
35
-
-
55349133352
-
Present and future drug treatments for chronic kidney diseases: Evolving targets in renoprotection
-
Perico N, Benigni A, Remuzzi G. Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection. Nat Rev Drug Discov 2008; 7: 936-953.
-
(2008)
Nat Rev Drug Discov
, vol.7
, pp. 936-953
-
-
Perico, N.1
Benigni, A.2
Remuzzi, G.3
-
36
-
-
10744229858
-
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial
-
Holdaas H, Fellstrom B, Jardine AG et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 2024-2031.
-
(2003)
Lancet
, vol.361
, pp. 2024-2031
-
-
Holdaas, H.1
Fellstrom, B.2
Jardine, A.G.3
-
37
-
-
4644278069
-
Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial
-
Fellstrom B, Holdaas H, Jardine AG et al. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial. Kidney Int 2004; 66: 1549-1555.
-
(2004)
Kidney Int
, vol.66
, pp. 1549-1555
-
-
Fellstrom, B.1
Holdaas, H.2
Jardine, A.G.3
-
38
-
-
49849102254
-
Fluvastatin in the prevention of renal transplant vasculopathy: Results of a prospective, randomized, double-blind, placebo-controlled trial
-
Seron D, Oppenheimer F, Pallardo LM et al. Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial. Transplantation 2008; 86: 82-87.
-
(2008)
Transplantation
, vol.86
, pp. 82-87
-
-
Seron, D.1
Oppenheimer, F.2
Pallardo, L.M.3
-
39
-
-
11144271126
-
Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants
-
Chisholm MA. Identification of medication-adherence barriers and strategies to increase adherence in recipients of renal transplants. Manag Care Interface 2004; 17: 44-48.
-
(2004)
Manag Care Interface
, vol.17
, pp. 44-48
-
-
Chisholm, M.A.1
-
40
-
-
4344626592
-
Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients
-
Vlaminck H, Maes B, Evers G et al. Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. Am J Transplant 2004; 4: 1509-1513.
-
(2004)
Am J Transplant
, vol.4
, pp. 1509-1513
-
-
Vlaminck, H.1
Maes, B.2
Evers, G.3
-
41
-
-
58149120959
-
Compliance of kidney transplant patients to the recommended lifestyle behaviours: Single centre experience
-
Gheith OA, El-Saadany SA, Abuo Donia SA et al. Compliance of kidney transplant patients to the recommended lifestyle behaviours: single centre experience. Int J Nurs Pract 2008; 14: 398-407.
-
(2008)
Int J Nurs Pract
, vol.14
, pp. 398-407
-
-
Gheith, O.A.1
El-Saadany, S.A.2
Abuo Donia, S.A.3
-
42
-
-
0842281681
-
Cigarette smoking in renal transplant recipients
-
Yavuz A, Tuncer M, Gurkan A et al. Cigarette smoking in renal transplant recipients. Transplant Proc 2004; 36: 108-110.
-
(2004)
Transplant Proc
, vol.36
, pp. 108-110
-
-
Yavuz, A.1
Tuncer, M.2
Gurkan, A.3
-
43
-
-
34047266333
-
Cigarette smoking as a risk factor for atherosclerosis and renal disease: Novel pathogenic insights
-
Mercado C, Jaimes EA. Cigarette smoking as a risk factor for atherosclerosis and renal disease: novel pathogenic insights. Curr Hypertens Rep 2007; 9: 66-72.
-
(2007)
Curr Hypertens Rep
, vol.9
, pp. 66-72
-
-
Mercado, C.1
Jaimes, E.A.2
-
45
-
-
48149112155
-
Sirolimus is associated with new-onset diabetes in kidney transplant recipients
-
Johnston O, Rose CL, Webster AC et al. Sirolimus is associated with new-onset diabetes in kidney transplant recipients. J Am Soc Nephrol 2008; 19: 1411-1418.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1411-1418
-
-
Johnston, O.1
Rose, C.L.2
Webster, A.C.3
-
46
-
-
33645083493
-
Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome
-
Sezer S, Akgul A, Altinoglu A et al. Posttransplant diabetes mellitus: impact of good blood glucose regulation on renal transplant recipient outcome. Transplant Proc 2006; 38: 533-536.
-
(2006)
Transplant Proc
, vol.38
, pp. 533-536
-
-
Sezer, S.1
Akgul, A.2
Altinoglu, A.3
-
47
-
-
48049100806
-
Role of remission clinics in the longitudinal treatment of CKD
-
Ruggenenti P, Perticucci E, Cravedi P et al. Role of remission clinics in the longitudinal treatment of CKD. J Am Soc Nephrol 2008; 19: 1213-1224.
-
(2008)
J Am Soc Nephrol
, vol.19
, pp. 1213-1224
-
-
Ruggenenti, P.1
Perticucci, E.2
Cravedi, P.3
|